Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The past, present, and future physiology and pharmacology of glucagon

Cell Metabolism(2022)10.1016/j.cmet.2022.10.001Source: DataRank Database

The past, present, and future physiology and pharmacology of glucagon is a research paper published in Cell Metabolism (2022). On theSindex it has a DataRank of 0. It has been cited 104 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access104 citations

Free full text

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 18.15)OA: greenTopics (30)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

David A. D’Alessio ORCID,Jonathan E. Campbell ORCID,Megan E. Capozzi ORCID

Live enrichment

PubMed:36323234 OpenAlex:https://openalex.org/W4308112307

NIDDK

Grant: K01 DK129417

NIDDK

Grant: R01 DK046492

NIDDK

Grant: R01 DK123075

NIDDK

Grant: R01 DK125353

NIDDK NIH HHS

Grant: T32 DK007012

FWCI

18.15

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9641554

publisherhttps://api.elsevier.com/content/article/PII:S1550413122004521?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1550413122004521?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cmet.2022.10.001

Fields of Study

Pancreatic function and diabetesDiabetes Treatment and ManagementDiabetes Management and ResearchHumansGlucagonReceptors, GlucagonDiabetes Mellitus, Type 2InsulinGlucagon-Secreting Cells

MeSH Terms

Diabetes Mellitus, Type 2GlucagonHumansInsulinReceptors, GlucagonGlucagon-Secreting Cells

Keywords

HyperglucagonemiaGlucagonGlucagon receptorCatabolismEndocrinologyInternal medicineDiabetes mellitusInsulinHormoneBiologyMedicineMetabolismdiabetesglucoseα cells

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of V1bR enhances glucose-stimulated insulin secretion by paracrine production of glucagon which activates GLP-1 receptor

10.6084/m9.figshare.26944614.v1figshare

Additional file 1 of V1bR enhances glucose-stimulated insulin secretion by paracrine production of glucagon which activates GLP-1 receptor

10.6084/m9.figshare.26944614figshare